TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT00721266 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT00781508 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT03908073 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01407822 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01543737 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT03851679 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT02401256 — Predictive Biomarker (PRD): CYP2B6 mRNA
Genes: CYP2B6
Study NCT03110744 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT03110744 — Predictive Biomarker (PRD): CDKN2A mRNA
Genes: CDKN2A; CDKN2; MTS1
Study NCT01165203 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03250247 — Predictive Biomarker (PRD): PTS mRNA
Genes: PTS
Study NCT03303885 — Predictive Biomarker (PRD): SDC1 mRNA
Genes: SDC1; SDC
Study NCT03303885 — Predictive Biomarker (PRD): FGF2 mRNA
Genes: FGF2; FGFB
Study NCT03303885 — Predictive Biomarker (PRD): FGF18 mRNA
Genes: FGF18; UNQ420/PRO856
Study NCT05913557 — Pharmacodynamic Biomarker (PDY): Error related negativity
Study NCT03531034 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03997539 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02105766 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT00389506 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study NCT00498862 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03768921 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00654485 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03313505 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study NCT04329975 — Surrogate Endpoint (SUR): Serum sodium
Study NCT04574427 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT02005133 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00508586 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00508586 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02234934 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT04223648 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT03486431 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study NCT02188121 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03640767 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02739984 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03742492 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00717353 — Predictive Biomarker (PRD): UGT2B7 mRNA
Genes: UGT2B7; UGTB2B9
Study NCT01616303 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study NCT01437878 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT02044471 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04341844 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study NCT04497246 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03558932 — Predictive Biomarker (PRD): PKM mRNA
Genes: PKM; OIP3; PK2; PK3; PKM2
Study NCT05007171 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT04664244 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04664244 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00988169 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02154269 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01428011 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01708083 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study NCT01429012 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT04269486 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT02826135 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00974883 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00198159 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00198159 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01892527 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01892527 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT01892527 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT02874651 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02874651 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03732222 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study NCT03732222 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT04035122 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00686179 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT03349333 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT04121416 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01087203 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT01387373 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00829166 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00829166 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01119560 — Predictive Biomarker (PRD): MYCN mRNA
Genes: MYCN; BHLHE37; NMYC
Study NCT04471597 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00101309 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00718861 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00186329 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT00666874 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03505697 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT01183416 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00461266 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02333240 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00858702 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02143518 — Predictive Biomarker (PRD): TLR9
Genes: CD289
Study NCT01654081 — Predictive Biomarker (PRD): ISG15 mRNA
Genes: ISG15; G1P2; UCRP
Study NCT01136226 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT04515927 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT01583582 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01583582 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02538666 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study NCT03743428 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03043963 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04641481 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT01167920 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00337298 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04095390 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04095390 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT00362037 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00395096 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT02717221 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02430363 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT02909166 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT02020603 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study NCT05712967 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study NCT02398396 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study NCT04286399 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT00628914 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT01934998 — Safety Biomarker (SAF): SLC6A3
Genes: DAT
Study NCT03139097 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT01266707 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study NCT01266707 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT01266707 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT04452812 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04318327 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT00291278 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00204126 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04130152 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04130152 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04130152 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04130152 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03828838 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT01377363 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01756300 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03230253 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT03230253 — Predictive Biomarker (PRD): ASPSCR1 mRNA
Genes: ASPSCR1; ASPL; RCC17; TUG; UBXD9; UBXN9
Study NCT03230253 — Predictive Biomarker (PRD): ZMYM2 mRNA
Genes: ZMYM2; FIM; RAMP; ZNF198
Study NCT03230253 — Pharmacodynamic Biomarker (PDY): Platelet-derived growth factor B
Genes: PDGFB; PDGF2; SIS
Study NCT02951546 — Predictive Biomarker (PRD): PNPLA3 mRNA
Genes: PNPLA3; ADPN; C22orf20
Study NCT02951546 — Predictive Biomarker (PRD): TM6SF2 mRNA
Genes: TM6SF2
Study NCT00001461 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03785197 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03780972 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study NCT02948777 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT03799003 — Predictive Biomarker (PRD): TNFRSF18 mRNA
Genes: TNFRSF18; AITR; GITR; UNQ319/PRO364
Study NCT01105741 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01450514 — Predictive Biomarker (PRD): PIP mRNA
Genes: PIP; GCDFP15; GPIP4
Study NCT00341952 — Predictive Biomarker (PRD): RTEL1 mRNA
Genes: RTEL1; C20orf41; KIAA1088; NHL
Study NCT04366479 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Nuclear factor erythroid 2-related factor 2
Genes: NFE2L2; NRF2
Study NCT04366479 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): NRF2 mRNA
Genes: NFE2L2; NRF2
Study NCT04366479 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02325505 — Predictive Biomarker (PRD): TSC1
Genes: KIAA0243; LAM; hamartin
Study NCT02325505 — Predictive Biomarker (PRD): TSC2
Genes: tuberin; LAM; PPP1R160
Study NCT00116636 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03185494 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT03185494 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT01709864 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT01146834 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03558893 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01982487 — Predictive Biomarker (PRD): Indoleamine 2,3-dioxygenase 1
Genes: IDO1; IDO; INDO
Study NCT02022007 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT02022007 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT02992470 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study NCT00703326 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00703326 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03988816 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03988816 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT03053089 — Predictive Biomarker (PRD): IDUA mRNA
Genes: IDUA
Study NCT01748396 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT01496573 — Pharmacodynamic Biomarker (PDY): Crk-like protein
Genes: CRKL
Study NCT01234402 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01234402 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT01234402 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05174143 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT02919475 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03935477 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02407574 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03907722 — Safety Biomarker (SAF): Pentraxin-related protein PTX3
Genes: PTX3; TNFAIP5; TSG14
Study NCT04872426 — Pharmacodynamic Biomarker (PDY): 5'-AMP-activated protein kinase subunit beta-1
Genes: PRKAB1; AMPK
Study NCT02089386 — Predictive Biomarker (PRD): SOX2 mRNA
Genes: SOX2
Study NCT02089386 — Predictive Biomarker (PRD): CDX2 mRNA
Genes: CDX2; CDX3
Study NCT03438942 — Predictive Biomarker (PRD): SLC46A1 mRNA
Genes: SLC46A1; G21; HCP1; PCFT
Study NCT02916979 — Predictive Biomarker (PRD): VSIR mRNA
Genes: VSIR; C10orf54; SISP1; VISTA; PP2135; UNQ730/PRO1412
Study NCT02916979 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT05201443 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT05201443 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study NCT03942510 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03775356 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02849704 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT03016468 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT01696318 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01716611 — Surrogate Endpoint (SUR): Serum sodium
Study NCT03077945 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00466674 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00466674 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT04386967 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00187707 — Predictive Biomarker (PRD): SLC22A5 mRNA
Genes: SLC22A5; OCTN2
Study NCT01417780 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study NCT00493116 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT01730677 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01208558 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01608009 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00227825 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00663377 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03012516 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00471861 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00471861 — Predictive Biomarker (PRD): VIP mRNA
Genes: VIP
Study NCT01411267 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT03215173 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02252887 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03432520 — Predictive Biomarker (PRD): Coagulation factor VIII
Genes: F8; F8C
Study NCT02024282 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03034200 — Predictive Biomarker (PRD): DRD2 mRNA
Genes: DRD2
Study NCT00594152 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02788916 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT00526045 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00897520 — Predictive Biomarker (PRD): EGR3 mRNA
Genes: EGR3; PILOT
Study NCT00443612 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00443612 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04012918 — Predictive Biomarker (PRD): Hormone receptor
Study NCT00315718 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01797120 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT01797120 — Predictive Biomarker (PRD): Hormone receptor
Study NCT02878824 — Predictive Biomarker (PRD): EDA mRNA
Genes: EDA; ED1; EDA2
Study NCT01108809 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02874716 — Predictive Biomarker (PRD): PPIA mRNA
Genes: PPIA; CYPA
Study NCT00935077 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03722199 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00182871 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02703623 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT04024462 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02054533 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02480075 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT01984476 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02834832 — Surrogate Endpoint (SUR): Bacterial count
Study NCT02904395 — Safety Biomarker (SAF): Lysosomal alpha-glucosidase
Genes: GAA
Study NCT03812211 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00358826 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03088228 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03088228 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study NCT04012268 — Predictive Biomarker (PRD): MMD mRNA
Genes: MMD; PAQR11
Study NCT04541706 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT04541706 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT00227279 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT03483688 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT03005847 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT03534934 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02896387 — Predictive Biomarker (PRD): TP63 mRNA
Genes: TP63; KET; P63; P73H; P73L; TP73L
Study NCT02896387 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT04610788 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT04610788 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04610788 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT00686036 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT01031901 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT00027469 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04330287 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04330287 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01874782 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02316093 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT01231152 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01641016 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03593304 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT03714776 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Angiotensinogen
Genes: AGT; SERPINA8
Study NCT03714776 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04235101 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00234234 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04173234 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT00969904 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00969904 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03931083 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT03931083 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT03809065 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02675231 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT02675231 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02675231 — Predictive Biomarker (PRD): Hormone receptor
Study NCT02675231 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02435563 — Predictive Biomarker (PRD): VASP mRNA
Genes: VASP
Study NCT02435563 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT04929093 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT02839278 — Pharmacodynamic Biomarker (PDY): T-lymphocyte activation antigen CD86
Genes: CD86; CD28LG2
Study NCT02839278 — Predictive Biomarker (PRD): CD80 mRNA
Genes: CD80; CD28LG; CD28LG1; LAB7